Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Qualification of Reference Standards and Working Standards – V 2.0

Posted on By

Analytical Method Development: SOP for Qualification of Reference Standards and Working Standards – V 2.0

Standard Operating Procedure for Qualification of Reference Standards and Working Standards in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/398/2025
Supersedes SOP/AMD/398/2022
Page No. Page 1 of 13
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

To lay down a procedure for the qualification, labeling, documentation, usage, and storage of pharmacopoeial reference

standards (RS) and secondary working standards (WS) used in the Analytical Method Development (AMD) department.

2. Scope

This SOP applies to all AMD personnel responsible for procuring, qualifying, using, and maintaining records related to reference and working standards within the pharmaceutical analytical laboratory.

3. Responsibilities

  • Analyst: Handles and maintains the integrity of RS and WS during analytical activities.
  • AMD Supervisor: Ensures compliance with qualification and documentation procedures.
  • QA Department: Verifies and audits standard qualification activities.
See also  Analytical Method Development: SOP for Bioburden Method Development for APIs - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the proper qualification, usage, and control of all standards used in analytical testing and method development.

5. Procedure

5.1 Procurement of Reference Standards

  1. Purchase RS from recognized sources such as USP, EP, BP, IP, or WHO reference standards.
  2. Verify certificate of analysis (CoA), lot number, and expiry date upon receipt.
  3. Log the RS in the Reference Standard Register (Annexure-1).

5.2 Qualification of Working Standards

  1. Select RS for the qualification of WS.
  2. Perform identity, assay, and impurity profiling on three replicate preparations.
  3. Calculate assigned potency of WS based on assay result relative to RS.
  4. Document all qualification results and assign a unique WS code (Annexure-2).

5.3 Labeling

  1. Affix label to RS and WS containers indicating:
    • Name of substance
    • Assigned potency (for WS)
    • Batch/Lot number
    • Qualification date
    • Expiry date
    • Storage condition
See also  Analytical Method Development: SOP for Transfer of Validated Method to QC - V 2.0

5.4 Storage

  1. Store standards in designated desiccators or refrigerators as per CoA/storage conditions.
  2. Restrict access to authorized personnel only.
  3. Maintain temperature log for the storage area.

5.5 Usage

  1. Withdraw minimal quantity required using a clean spatula or scoop.
  2. Record each usage in the WS/RS usage log (Annexure-3).
  3. Avoid contamination during withdrawal; do not return excess material to the original container.

5.6 Requalification and Expiry

  1. Assign requalification period for WS (e.g., 6 months) based on stability data.
  2. Before expiry, evaluate WS potency and assign new qualification if applicable.
  3. Destroy expired standards as per the destruction SOP and document appropriately.

6. Abbreviations

  • RS: Reference Standard
  • WS: Working Standard
  • AMD: Analytical Method Development
  • CoA: Certificate of Analysis

7. Documents

  1. Reference Standard Register – Annexure-1
  2. Working Standard Qualification Record – Annexure-2
  3. RS/WS Usage Log – Annexure-3

8. References

  • ICH Q6A – Specifications: Test Procedures and Acceptance Criteria
  • USP General Chapter <1058> Analytical Instrument Qualification
  • WHO Guidelines on Quality Control of Pharmaceutical Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Ananya Tripathi Sachin Nanda Dr. Harshita Goyal
Designation AMD Analyst QA Reviewer Head – Analytical Method Development
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Reference Standard Register

RS Code Name Source Lot No. Expiry Storage
RS-398-01 Paracetamol USP U1234 12/2026 2–8°C

Annexure-2: Working Standard Qualification Record

Includes detailed assay results, comparison with RS, chromatograms, calculation of assigned potency, analyst and reviewer initials.

Annexure-3: RS/WS Usage Log

Date Standard Used For Qty Used By Remarks
28/05/2025 WS-Paracetamol Assay Validation 50 mg Ananya —

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Updated WS requalification and labeling format Annual Review Dr. Harshita Goyal
15/05/2022 1.0 Initial Issue New SOP QA Head
See also  Analytical Method Development: SOP for Accuracy Assessment Using Recovery Study - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Handling and Documentation of Raw Analytical Data – V 2.0
Next Post: Analytical Method Development: SOP for Documentation of Analytical Calculations and Worksheets – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version